rs139956524

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000069.3(CACNA1S):​c.2440G>A​(p.Ala814Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00191 in 1,592,980 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 6 hom. )

Consequence

CACNA1S
NM_000069.3 missense

Scores

9
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 3.32
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.024012804).
BP6
Variant 1-201069522-C-T is Benign according to our data. Variant chr1-201069522-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 294744.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Benign=1, Uncertain_significance=1}. Variant chr1-201069522-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00131 (200/152254) while in subpopulation NFE AF= 0.00237 (161/68024). AF 95% confidence interval is 0.00207. There are 0 homozygotes in gnomad4. There are 89 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 6 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA1SNM_000069.3 linkuse as main transcriptc.2440G>A p.Ala814Thr missense_variant 18/44 ENST00000362061.4 NP_000060.2
CACNA1SXM_005245478.4 linkuse as main transcriptc.2440G>A p.Ala814Thr missense_variant 18/43 XP_005245535.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA1SENST00000362061.4 linkuse as main transcriptc.2440G>A p.Ala814Thr missense_variant 18/441 NM_000069.3 ENSP00000355192 P2

Frequencies

GnomAD3 genomes
AF:
0.00131
AC:
200
AN:
152136
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00237
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.00121
AC:
254
AN:
210546
Hom.:
0
AF XY:
0.00119
AC XY:
134
AN XY:
112358
show subpopulations
Gnomad AFR exome
AF:
0.000293
Gnomad AMR exome
AF:
0.000458
Gnomad ASJ exome
AF:
0.00248
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000310
Gnomad FIN exome
AF:
0.000164
Gnomad NFE exome
AF:
0.00205
Gnomad OTH exome
AF:
0.00188
GnomAD4 exome
AF:
0.00198
AC:
2846
AN:
1440726
Hom.:
6
Cov.:
31
AF XY:
0.00190
AC XY:
1357
AN XY:
714162
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.000580
Gnomad4 ASJ exome
AF:
0.00269
Gnomad4 EAS exome
AF:
0.0000256
Gnomad4 SAS exome
AF:
0.000219
Gnomad4 FIN exome
AF:
0.000134
Gnomad4 NFE exome
AF:
0.00236
Gnomad4 OTH exome
AF:
0.00184
GnomAD4 genome
AF:
0.00131
AC:
200
AN:
152254
Hom.:
0
Cov.:
32
AF XY:
0.00120
AC XY:
89
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.000457
Gnomad4 AMR
AF:
0.000850
Gnomad4 ASJ
AF:
0.000865
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000189
Gnomad4 NFE
AF:
0.00237
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.00196
Hom.:
2
Bravo
AF:
0.00132
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00209
AC:
18
ExAC
AF:
0.00100
AC:
120

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 08, 2021This variant is associated with the following publications: (PMID: 25132214, 25735680, 27153395) -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024- -
not specified Benign:1
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
CACNA1S-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 08, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Hypokalemic periodic paralysis, type 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Malignant hyperthermia, susceptibility to, 5 Benign:1
Likely benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthSep 20, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.060
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.52
D;D
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.32
FATHMM_MKL
Benign
0.54
D
LIST_S2
Uncertain
0.95
D;D
M_CAP
Benign
0.078
D
MetaRNN
Benign
0.024
T;T
MetaSVM
Uncertain
0.38
D
MutationAssessor
Benign
2.0
.;M
MutationTaster
Benign
0.60
N;N
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.4
N;N
REVEL
Uncertain
0.30
Sift
Uncertain
0.026
D;D
Sift4G
Uncertain
0.0020
D;D
Polyphen
0.0080
.;B
Vest4
0.36
MVP
0.90
MPC
0.10
ClinPred
0.045
T
GERP RS
2.7
Varity_R
0.12
gMVP
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139956524; hg19: chr1-201038650; COSMIC: COSV99054144; API